Alrasheed, N.M.; Almuthanbi, L.A.; Alotaibi, R.R.; Alonazi, A.S.; Alamin, M.A.; Alshammari, T.K.; Alkhelb, D.A.; Bin Dayel, A.F.; Alomar, H.A.; Elnagar, D.M.;
et al. Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis. Pharmaceuticals 2025, 18, 1834.
https://doi.org/10.3390/ph18121834
AMA Style
Alrasheed NM, Almuthanbi LA, Alotaibi RR, Alonazi AS, Alamin MA, Alshammari TK, Alkhelb DA, Bin Dayel AF, Alomar HA, Elnagar DM,
et al. Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis. Pharmaceuticals. 2025; 18(12):1834.
https://doi.org/10.3390/ph18121834
Chicago/Turabian Style
Alrasheed, Nawal M., Lama A. Almuthanbi, Rana R. Alotaibi, Asma S. Alonazi, Maha A. Alamin, Tahani K. Alshammari, Dalal A. Alkhelb, Anfal F. Bin Dayel, Hatun A. Alomar, Doaa M. Elnagar,
and et al. 2025. "Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis" Pharmaceuticals 18, no. 12: 1834.
https://doi.org/10.3390/ph18121834
APA Style
Alrasheed, N. M., Almuthanbi, L. A., Alotaibi, R. R., Alonazi, A. S., Alamin, M. A., Alshammari, T. K., Alkhelb, D. A., Bin Dayel, A. F., Alomar, H. A., Elnagar, D. M., & Alrasheed, N. M.
(2025). Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis. Pharmaceuticals, 18(12), 1834.
https://doi.org/10.3390/ph18121834
